Investing Ideas
/
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Header cover image

U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED May 18, 2024

Companies with a Value score of at least 3, ordered by Value score

443 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	LEGN Legend Biotech	US$45.16	4.4%	-35.2%	US$8.2b	US$85.20	PS24x	E62.7%	n/a
	DMTK DermTech	US$0.50	-20.0%	-78.2%	US$17.3m	US$2.04	PS1.1x	E11.3%	n/a
	FAMD.F Futura Medical	UK£0.50	-5.7%	-9.9%	UK£119.7m	UK£1.59	PS38.6x	E111.8%	n/a
	YS YS Biopharma	US$0.98	0.8%	-22.4%	US$184.2m	US$4.14	PS2.4x	E58.3%	n/a
	AGIO Agios Pharmaceuticals	US$34.34	4.1%	31.6%	US$1.9b	US$41.67	PS66.3x	E31.3%	n/a
	PSTV Plus Therapeutics	US$2.24	3.7%	-42.3%	US$9.6m	US$16.50	PS1.6x	E-0.9%	n/a
	SNDL SNDL	US$2.46	7.0%	39.8%	US$647.4m	US$3.63	PB0.7x	E158.5%	n/a
	HROW Harrow	US$16.76	44.5%	-21.4%	US$593.0m	US$26.90	PS4.3x	E75.6%	n/a
	ATRA Atara Biotherapeutics	US$0.61	15.1%	-71.1%	US$73.5m	US$4.18	PS2.1x	E45.8%	n/a
	PRTA Prothena	US$22.52	5.5%	-69.5%	US$1.2b	US$64.75	PS13.6x	E36.6%	n/a
	CLVL.F Clinuvel Pharmaceuticals	AU$10.00	2.4%	-16.2%	AU$773.9m	AU$16.57	PE25.7x	E12.9%	0.3%

Page 19 of 19